Tang Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Tang Capital Management’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,088	Closed	-$106K	–	115
2023 Q1	$106K	Hold	5,088	–	–	0.02%	100
2022 Q4	$104K	Sell	5,088 -46,444	-90%	-$875K	0.02%	85
2022 Q3	$1.42M	Hold	51,532	–	–	0.17%	77
2022 Q2	$1.36M	Hold	51,532	–	–	0.21%	56
2022 Q1	$4.12M	Hold	51,532	–	–	0.82%	33
2021 Q4	$10.5M	Hold	51,532	–	–	2.11%	12
2021 Q3	$16.7M	Hold	51,532	–	–	3.46%	10
2021 Q2	$13.4M	Buy	51,532 +26,532	+106%	+$8.08M	2.66%	7
2021 Q1	$9.65M	Buy	+25,000	New	+$10.1M	2.72%	6

Other funds holding VINC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Tang Capital Management's VINC Position: Q2 2023 in Review

Tang Capital Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2023, closing a stake of 5,088 shares — an estimated $106K sold.

Tang Capital Management first reported a position in VINC in Q1 2021 and held it in 9 quarters. The position peaked at $16.7M in Q3 2021. 35 funds tracked by Wall St. Rank hold VINC as of Q2 2023.

Tang Capital Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Tang Capital Management sold 5,088 Vincerx Pharma, Inc. Common Stock shares in Q2 2023, an estimated $106K.
Tang Capital Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Tang Capital Management's Vincerx Pharma, Inc. Common Stock position peaked at $16.7M in Q3 2021.
35 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2023.

Based on Tang Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.